Transcervical carotid artery stenting compared to transfemoral carotid artery stenting and carotid endarterectomy: perioperative and short-term results from a single center
Frontiers in Cardiovascular Medicine · 03.06.2026 · 13
DOI: 10.3389/fcvm.2026.1743275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 03.06.2026. Verfasst von Wenxu Jin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Carotid artery stenosis is a major cause of ischemic stroke. Various revascularization strategies exist, including Carotid Endarterectomy (CEA), Transfemoral Carotid Artery Stenting (TF-CAS), and Transcervical Carotid Artery Stenting (TC-CAS). This study aimed to compare the perioperative outcomes and six-month follow-up results among patients undergoing TC-CAS, TF-CAS, and CEA for carotid artery stenosis.
Methods
A retrospective analysis was performed on 220 patients undergoing carotid revascularization from 2020 to 2024. Patients were divided into three groups: TC-CAS (50), TF-CAS (81), and CEA (89). Primary endpoints included perioperative stroke and complications; secondary endpoints assessed six-month restenosis and stroke/TIA events.
Results
Perioperative stroke rates were low and comparable among all groups (TF-CAS 2.5%, TC-CAS 2.0%, CEA 1.1%; P = 0.802). Cranial nerve injury occurred exclusively in the CEA group. Six-month restenosis rates showed no significant difference (TF-CAS 3.7%, TC-CAS 2.0%, CEA 4.5%; P = 0.752), with no stroke or TIA events observed in the TC-CAS group. Hospital costs were significantly lower in the CEA group (25.0 ± 9.8 × 10 3 CNY) compared to TF-CAS (57.6 ± 22.8 × 10 3 CNY) and TC-CAS (56.4 ± 20.1 × 10 3 CNY) ( P < 0.001).
Conclusion
TC-CAS is a feasible and promising alternative to TF-CAS and CEA, offering favorable perioperative safety and short-term clinical outcomes. It is particularly suitable for patients with high-risk anatomy, but longer-term studies are required to confirm sustained efficacy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Zitieren
APA
Jin, W., Ni, H., Huang, C., Pan, L., Qiu, Y., Huang, J., & Yu, G. (2026). Transcervical carotid artery stenting compared to transfemoral carotid artery stenting and carotid endarterectomy: perioperative and short-term results from a single center. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1743275
Vancouver
Jin W, Ni H, Huang C, Pan L, Qiu Y, Huang J, et al. Transcervical carotid artery stenting compared to transfemoral carotid artery stenting and carotid endarterectomy: perioperative and short-term results from a single center. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1743275
BibTeX
@article{Jin2026,
author = {Jin, Wenxu and Ni, Haizhen and Huang, Chongqing and Pan, Lemen and Qiu, Yihui and Huang, Jingyong and Yu, Guanfeng},
title = {Transcervical carotid artery stenting compared to transfemoral carotid artery stenting and carotid endarterectomy: perioperative and short-term results from a single center},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1743275}
}
EUVIMED